Regeneron Pharmaceuticals traded at $596.56 this Tuesday July 5th, increasing $1.16 or 0.19 percent since the previous trading session. Looking back, over the last four weeks, Regeneron Pharmaceuticals gained 2.05 percent. Over the last 12 months, its price rose by 2.46 percent. Looking ahead, we forecast Regeneron Pharmaceuticals to be priced at 579.26 by the end of this quarter and at 533.44 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
596.56
Daily Change
0.19%
Yearly
2.46%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Kyowa Hakko Kirin 3,115.00 35.00 1.14% -21.93%
Astellas Pharma 2,125.00 29.50 1.41% 11.58%
AbbVie 153.94 0.14 0.09% 33.02%
Agenus 2.35 0.39 19.90% -56.32%
Agios Pharmaceuticals 25.28 1.92 8.22% -55.85%
Alimera Sciences 5.24 -0.22 -3.98% -41.88%
Alnylam Pharmaceuticals 150.99 2.74 1.85% -13.41%
Amgen 246.73 1.18 0.48% 1.26%
AstraZeneca 10,800.00 -8.00 -0.07% 23.84%
Biogen 212.58 1.95 0.93% -38.36%
Bluebird Bio 5.02 0.74 17.32% -83.82%
BioMarin Pharmaceutical 86.43 1.45 1.70% 2.19%
Bristol-Myers Squibb 75.96 -0.88 -1.15% 13.97%
Esperion Therapeutics 6.97 0.52 8.06% -64.90%
Gilead Sciences 61.00 -0.04 -0.06% -10.83%
GlaxoSmithKline 1,786.60 -16.00 -0.89% 24.57%
Intercept Pharmaceuticals 14.87 0.74 5.24% -21.90%
Incyte Corp 79.25 1.58 2.03% -4.91%
Ionis Pharmaceuticals 37.86 -0.20 -0.53% -3.74%
J&J 178.00 -1.52 -0.85% 5.97%
Eli Lilly 327.18 2.47 0.76% 38.98%
Merck & Co 92.64 0.22 0.24% 18.60%
Moderna Inc 155.62 5.67 3.78% -33.31%
Neurocrine Biosciences 98.30 -0.95 -0.96% 0.87%
Novartis 80.91 -0.74 -0.91% -4.31%
Novartis 84.28 -0.08 -0.09% -7.97%
Iveric bio Inc. 10.15 0.75 7.98% 18.16%
Opthea Ltd 1.17 0 0% -16.43%
Puma Biotechnology 2.66 -0.12 -4.32% -69.43%
Pfizer 51.20 -0.69 -1.32% 30.31%
Ultragenyx Pharmaceutical 63.80 1.15 1.84% -30.21%
Regeneron Pharmaceuticals 596.56 1.16 0.19% 2.46%
Roche Holding 319.00 -3.60 -1.12% -9.76%
Seattle Genetics 176.77 -3.34 -1.85% 15.91%
Sanofi 50.18 -0.83 -1.63% -2.43%
Sarepta Therapeutics 75.74 0.03 0.04% 3.43%
Teva Pharmaceutical Industries Ltd 2,746.00 0 0% -13.97%
United Therapeutics 237.15 -0.85 -0.36% 28.00%
Vertex Pharmaceuticals 288.98 1.66 0.58% 44.45%

Indexes Price Day Year
US500 3834 6.06 0.16% -11.74%
USND 11322 194.39 1.75% -22.79%
USNDX 11814 222.33 1.92% -20.10%

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious diseases. The Company commercializes medicines and product candidates for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases, and rare diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Dupixent (dupilumab) Injection, Libtayo (cemiplimab) Injection, Praluent (alirocumab) Injection, Kevzara (sarilumab) Solution for Subcutaneous Injection, Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion.